Document qkXZmJYYwqrO8161eLgZ5RgrG

Case Diagnosis: JCML clinical lab operating at 100% capacity, processing 30% more cases than anticipated with 99+% concordance between primary diagnosis & secondary pathology review. CDC Case Accrual: Logistical issues affecting NHL accrual rate have been successfully resolved. All Exposure Assessment: Exposure Assessment fully operational, and Exposure Re-creation Committee reorganized apart from IPHS. Exposure activities will be highlighted at annual meeting. External Review Panels: ERP Chair will be chosen at Asilomar, and Ethics panel will resume Fund Balance at API 1Q04 = $5,193,061 1 General: 2004 report generation went like clockwork, with mininal API time required to generate report Irons Field Expenses: Total T&E expenses are currently 1% ($15K) over budget and need to be UCHSC: $874,031 was disbursed in 2004. First-half 2004 total expenses were 100+% (-$1 MM) above Subcontracts: Total UCHSC Subcontractor expenses were -$800K above projected budget, attibuted AHS: 2004 expenses include both 10 & 20 due to timing of new AHS contract. Labor costs high due (J) length of time in Shanghai, but travel savings have kept total expenses 1% ($28K) under budget. I m r Fudan University: 30% additional case load, and transfer of CDC & IPHS activities has increased rate r s:I SRP/ERP: Total expenses 2% ($9K) over budget following 1004 budget adjustment and unanticipated () () r Communications (APCO): Low 2004 activity; cummulative variance of 9% under budget C ;a G) oI c..n (J) c..n I'V I'V Outside Legal Council: cummulative variance of 12% under budget QAlQC: proposal requested from Judy Baldwin, per Technical Committee recommendation. API Administrative Costs: 10% over budget for the quarter due to high activity associated with Income detail worksheet: per Technical Committee request, line item added for UCHSC interest. UCHSC grant requires close monitoring due to large 2Q04 expenses and new case cost structure API administrative expenses requires close monitoring to contain costs. Establish new Fudan University and Dr. Ironsfield expense contracts (in progress). (J) I Need to reconcile UCHSC statement - they have a $105 error. m r r Technical Budget Work Group Acceptance: s:I Oversight Committee Acceptance: () Posted to website: () r C ;a G) oI c..n (J) c..n I'V c..> SH ELL-MCCLU RG-056524 Benzene Health Research Consortium 2004 Financial Report Overview Case Diagnosis: JCML clinical lab operating at 100% capacity, processing 30% more cases than anticipated with 99+% concordance between primary diagnosis & secondary pathology review. CDC Case Accrual: Logistical issues affecting NHL accrual rate have been successfully resolved. All Exposure Assessment: Exposure Assessment fully operational, and Exposure Re-creation Committee reorganized apart from IPHS. Exposure activities will be highlighted at annual meeting. External Review Panels: ERP Chair will be chosen at Asilomar, and Ethics panel will resume Fund Balance at API 1Q04 = $5,193,061 1 General: 2004 report generation went like clockwork, with mininal API time required to general report Irons Field Expenses: Total T&E expenses are currently 1% ($15K) over budget and need to be UCHSC: $874,031 was disbursed in 2004. First-half 2004 total expenses were 100+% (-$1 MM) above Subcontracts: Total UCHSC Subcontractor expenses were -$800K above projected budget, attibuted AHS: 2004 expenses include both 10 & 20 due to timing of new AHS contract. Labor costs high due (J) length of time in Shanghai, but travel savings have kept total expenses 1% ($28K) under budget. I m r Fudan University: 30% additional case load, and transfer of CDC & IPHS activities has increased rate r s:I SRP/ERP: Total expenses 2% ($9K) over budget following 1004 budget adjustment and unanticipated () () r Communications (APCO): Low 2004 activity; cummulative variance of 9% under budget C ;a G) oI c..n Page 1 of 62 (J) c..n cI'.V.n AUTO DATE Benzene Health Research Consortium 2Q04 Financial Report Overview Outside Legal Council: cummulative variance of 12% under budget QAlQC: proposal requested from Judy Baldwin, per Technical Committee recommendation. API Administrative Costs: 10% over budget for the quarter due to high activity associated with Income detail worksheet: per Technical Committee request, line item added for UCHSC interest. UCHSC grant requires close monitoring due to large 2Q04 expenses and new case cost structure API administrative expenses requires close monitoring to contain costs. Establish new Fudan University and Dr. Ironsfield expense contracts (in progress). (J) I Need to reconcile UCHSC statement - they have a $105 error. m r r Technical Budget Work Group Acceptance: s:I Oversight Committee Acceptance: () Posted to website: () r C ;a G) oI c..n Page 2 of 62 (J) c..n I'V (J) AUTO DATE LT 8/6/04 BJ 7/26/04 Benzene Health Research Consortium 2Q04 Financial Report Overview (J) I m r r sI : () () r C ;a G) oI c..n Page 3 of 62 AUTODATE (J) c..n I'V -.....J Item AHScienc es CaseControl Study DP&ME Studies (UCHSC) Irons(T & E) Fudan University Total Research Costs Scientific Review Panel Ethics Review Panel Benzene Health Research Consortium Approved Program Budget Approved Original Cost Revised Cost 2Q04 Financial R- ......... Unapproved Approved Changes not Approved Estimate Estimate approved (June 11 NOV 03 OC 21 APR 04 OC (Jan. 2001) (Dec. 2001) 2003) mtg mtg $1,595,000 $2,283,095 $2,283,095 $2,283,095 $2,283,095 $13,665,017 $15,258,017 $1,253,428 $1,253,428 $165,700 $190,555 $16,679,145 $18,985,095 $15,258,000 $1,597,273 $661,000 $19,799,368 $14,508,000 $1,413,428 $230,000 $18,434,523 $14,508,000 $1,413,428 $230,000 $18,434,523 $648,000 $551,736 $300,000 $300,000 $216,000 $192,000 $64,000 $64,000 External Pathology & Cytogenet ics Workgrou (J) ps(Cost in I UC cost) m r Total Panel Costs r API Seed s:I Monies () Outside () r Counsel C ;a G) oI c..n (J) c..n I'V ex> $450,000 $500,000 $130,000 $994,000 $0 $500,000 $0 $743,736 $0 $100,576 $0 $364,000 $0 $100,000 $0 $364,000 $0 $100,000 Page 4 of 62 AUTO DATE Public Affairs QAlQC Activities UCHSC Interest contingency Miscellaneous Costs Subtotal API Admin. GRAND TOTAL Benzene Health Research Consortium Approved Program Budget 2Q04 Financial Report $1,000,000 $1,000,000 $960,600 $550,000 $550,000 $225,000 $190,855 $1,690,855 $18,820,000 $941,000 $0 $1,725,000 $21,704,095 $1,085,205 $100,000 $0 $1,161,176 $21,704,280 $1,085,019 $100,000 ($100,000) $390,272 $1,040,272 $19,838,795 $1,245,205 $100,000 $0 $290,272 $1,040,272 $19,838,795 $1,245,205 $19,761,000 $22,789,300 $22,789,299 $21,084,000 $21,084,000 Notes by API Notes/As sumption s for Dec. 2001 revised budget: - The total research costs have changed as a result of - Panel costs assume that there will be only one face-to- face meeting for each panel each year. LT 7/19/04 (J) I m r r sI : () () r C ;a G) oI c..n Page 5 of 62 (J) c..n I'V <D AUTO DATE Cost Centers Income Benzene Health Research Consortium Executive Summary 2Q04 Financial Report Project # Inception Thru December 2003 Actuals Actuals Jan - June 2004 $ 15,257,275 $ 1,492,621 $ 16,749,895 Cumulative Actuals Inception Thru 2Q04 $ 16,749,895 Budget (actual + projected 2004 2005 $1,461,334 Cost Centers UCHSC* Irons-Field Expense* Applied Health Sciences Fudan University X8105 X8106 X8107 X8108 Scientific & Ethics Panels X8109 Communications X8103 Outside Legal Counsel X8104 QAlQC Support X8110 API Administrative X8100 Contingency Total Expenses Fund Balance 7,515,759 539,486 951,892 31,981 82,854 290,866 33,208 594,670 101,473 874,031 189,320 168,623 27,755 12,529 790 3,360 138,238 $ 10,142,189 $ 1,414,645 $ 5,115,086 $ 77,975 8,389,790 728,806 1,120,515 59,736 8,389,790 728,806 1,120,515 59,736 95,383 291,656 36,567 95,383 291,656 36,567 732,908 101,473 732,908 101,473 $ 11,556,834 $ 11,556,834 ~9~1~.9R1 ** 874,030 111,016 196,681 14,575 1,748,060 222,032 441,867 29,148 76,750 30,000 8,349 12,500 137,100 79,250 60,000 16,698 25,000 123,330 188,799 $ 1,461,001 $ 2,934,184 ::::::I~!1U~91 r:::::::::::::::::::::$::I~gl;g'-m:r:rrmr (J) I ::~!:9@:::!!::~MqJ.~~:::~:9Q~:::!I!~QGI!:::~g::::::::::::iii::: m * amount disbursed by API r r sI : () () LT 7/29/04 r C ;a G) oI c..n (J) c..n c..> o **$2,166,979 of fund balance Page 6 of 62 AUTO DATE Benzene Health Research Consortium Executive Summary 2Q04 Financial Report income &expenses) 2006 $1,461,333 2007 $1,461,333 Projected Expenses Program Budget I I$ 21,133,895 $ 21,084,000 1,748,060 222,030 449,985 29,148 1,748,060 222,028 45,833 29,148 14,508,000 1,505,912 2,254,880 161,755 14,508,000 1,413,428 2,283,095 230,000 74,250 60,000 16,698 25,000 123,200 $ 2,748,371 47,396 79,135 16,698 25,000 123,200 $ 2,336,498 373,029 364,000 520,791 550,000 95,010 100,000 87,500 100,000 1,239,738 1,245,205 290,272 290,272 '..._ _ _ _..1 I I$ 21,036,887 $ 21,084,000 ::::::::::::::::::::t!11;:1@1::::::: :::r::::::::::::::::::::::t!~.:: (J) I m r r Income s:I Detail () sponsors $16,500,000 () 2001 seed $15,000 r C ;a G) oI c..n Page 7 of 62 (J) c..n c..> .....lo. AUTODATE llJ f- ooe:( f::J e:( C\I <D '0 ex:> Q) Ocol D... SH ELL-MCCLU RG-056532 MAP contrib. API interest UCHSC interest TOTAL $200,000 $34,895 $0 $16,749,895 Benzene Health Research Consortium Executive Summary 2Q04 Financial Report (J) I m r r sI : () () r C ;a G) oI c..n Page 9 of 62 AUTO DATE (J) c..n c..> c..> Benzene Health Research Consortium Case Accrual 2Q04 Financial Report variance = cases "case predictions based on'hlstorlcal estimates; these are not target numbers of cases required for study completion LT7/19/04 BJ 7/26/04 (J) I m r r sI : () () r C ;a G) oI c..n (J) c..n c..> ..j:::o. Page 10 of 62 AUTODATE Benzene Health Research Consortium Case Accrual 2Q04 Financial Report (J) I m r r sI : () () r C ;a G) oI c..n Page 11 of 62 AUTODATE (J) c..n c..> c..n Et "t(o~Jo)a.00:). c_ O CO 0"6 ..c c (.) CO .OC..O..)L"CL- (J)"<j" a0:)a0 .~.cC-\l CO CO 0) :::J I t; c 0) (.) 0) 0) N (J) C CO ~o llJ oof- f- ::J C\I <D '0 C\I 0) Ol CO D.... SH ELL-MCCLU RG-056536 Et "t(o~Jo)a.00:). c_ O CO 0"6 ..c c (.) CO .OC..O..)L"CL- (J)"<j" a0:)a0 .~.cC-\l CO CO 0) :::J I t; c 0) (.) 0) 0) N (J) C CO ~o llJ oof- f- ::J C\I <D '0 cry 0) Ol CO D.... SH ELL-MCCLU RG-056537 Et "t(o~Jo)a.00:). c_ O CO 0"6 ..c c (.) CO .OC..O..)L"CL- (J)"<j" a0:)a0 .~.cC-\l CO CO 0) :::J I t; c 0) (.) 0) 0) N (J) C CO ~o llJ oof- f- ::J C\I <D '0 "<j" 0) Ol CO D.... SH ELL-MCCLU RG-056538 Et "t(o~Jo)a.00:). c_ O CO 0"6 ..c c (.) CO .OC..O..)L"CL- (J)"<j" a0:)a0 .~.cC-\l CO CO 0) :::J I t; c 0) (.) 0) 0) N (J) C CO ~o llJ oof- f- ::J C\I <D '0 L() 0) Ol CO D.... SH ELL-MCCLU RG-056539 Et "t(o~Jo)a.00:). c_ O CO 0"6 ..c c (.) CO .OC..O..)L"CL- (J)"<j" a0:)a0 .~.cC-\l CO CO 0) :::J I t; c 0) (.) 0) 0) N (J) C CO ~o llJ oof- f- ::J C\I <D '0 <D 0) Ol CO D.... SH ELL-MCCLU RG-056540 Et "t(o~Jo)a.00:). c_ O CO 0"6 ..c c (.) CO .OC..O..)L"CL- (J)"<j" a0:)a0 .~.cC-\l CO CO 0) :::J I t; c 0) (.) 0) 0) N (J) C CO ~o llJ oof- f- ::J C\I <D '0 r--- 0) Ol CO D.... SH ELL-MCCLU RG-056541 Benzene Health Research Consortium Cash Flow Statement 2Q04 Financial Report :f!gM,e~r~!iM!WM~~:rrrr }r.@!c!j'.::%!'!'W'<l.l.~!,!::::::::::::::::::' LT 7/29/04 NOTE,! $$JQ$'~Qjlin bank at API (J) I m r r sI : () () r C ;a G) ocI.n 18 of 62 AUTODATE (J) c.n .,j:::o. I'V Benzene Health Research Consortium Cash Flow Statement 2Q04 Financial Report (J) I m r r sI : () () r C ;a G) oI c..n 19 of 62 AUTODATE (J) c..n ..j:::o. c..> Cost Centers Benzene Health Research Consortium Program Expense Summary 2Q04 Financial Report (J) I m r r sI : () () r C ;a G) oI c..n (J) c..n ..j:::o. ..j:::o. Benzene Health Research Consortium Program Expense Summary 2Q04 Financial Report r-------------~------~----------~~~----------~,--~~~~, Cost Centers (J) I m rr, s: () () r C ;a G,) o c..n (J) c..n ..j:::o. Page 21 of 62 AUTODATE c..n Benzene Health Research Consortium Program Expense Summary 2Q04 Financial Report LT 7/29/04 Amt.At UCHSC & Irons Field exp. Bank acct $11,556,834 $11 ,178,458 $378,376 $77,182 In Irons' field exp bank acct as of 6/30104 Total as of $378,376 6/30104 API disbursed by period (includes pre-payments for UCHSC & Irons Field) 24,600 1,577,811 7,652,678 318,759 258,097 310,244 66,019 1,348,626 IT 874,030 IT 874,030 IT 874,030 IT 874,030 IT (J) I m r r sI : () () r C ;a G) ocI.n (J) c.n.,j:::o. Page 22 of 62 AUTODATE (J) Benzene Health Research Consortium Program Expense Summary 2Q04 Financial Report r-------------~------~----------~~~----------~,--~~~~, Cost Centers LT 7/29/04 API disbursed by period (includes pre-payments for UCHSC & Irons Field) 874,030 IT 874,030 IT 874,030 16,921,638 (J) I m rr, s: () () r C ;a G,) oc.n (J) c.n.,j:::o. Page 23 of 62 -.....J AUTODATE Benzene Health Research Consortium UCHSC Grant 2Q04 Financial Report (J) I m r r UCHSC s:I statement error for travel, () off by +$105 () r C ;a G) oI c..n (J) c..n Page 24 of 62 AUTODATE ..j:::o. ex> Benzene Health Research Consortium UCHSC Grant 2Q04 Financial Report (J) I m r r sI : () () r C ;a G) oI c..n (J) c..n Page 25 of 62 AUTODATE ..j:::o. <D Cost Centers LT 8/6/04 BJ 8/04/04 (J) I m r r sI : () () r C ;a G) ocI.n (J) cc..nn o Am!. paid UCHSCto date: Am!. expensed to date: Am!. In UCHSC bank acct: Benzene Health Research Consortium UCHSC Grant 2Q04 Financial Report 3rd Otr 4th Otr 3rd Otr 4th Otr 1st Otr 2nd Otr 3rd Otr 4th Otr (Adjusted 4003: $48,839 attributed to UCHSC in 3003 Report has been reallocated to Contingency: $25,000 preconsortium gran tin 2001; $3,600 for IRB Review in 2002; $20,239 for EMBSI "feasibility $8,389,790 study" in 2002) (Adjusted 4003: 2001 costs had been double expensed in 2002 column; ($523,807) adjusment $8,088,596 made in 4003) $301,194 Page 26 of 62 AUTODATE UCHSC (x81 05) Cost Centers Benzene Health Research Consortium UCHSC Grant 2Q04 Financial Report 2006 2nd Olr. 3r.d Olr. 4lh Olr. 2007 2nd Olr. 3r.d Olr. 4lh Olr. LT 8/6/04 BJ 8/04/04 (J) I m r r sI : () () r C ;a G) oI c..n (J) c..n c..n .....lo. Page 27 of 62 AUTODATE LT 8/6/04 BJ 8/04/04 "Actual expenses" from UC Office of Grants & Contracts report. Benzene Health Research Consortium UCHSC Subcontract 2Q04 Financial Report (J) I m r r sI : () () r C ;a G) oI c..n Page 28 of 62 (J) c..n c..n I'V AUTODATE Cost Centers 1st & 2nd Benzene Health Research Consortium Irons Field Expenses 2Q04 Financial Report 4Q03 ADJUSTME NT2001/2002 expense underrecord ed; -0$114,289 adjustment (J) I m r r sI : () () r Amt paid to C Irons to numbers as ;a date $728,806 of 06/30104 Amt Irons G) has spent $651,624 oI c..n (J) c..n Page 29 of 62 c..n c..> AUTODATE Cost Centers 2nd Olr. 3r.d Olr. 4lh Olr. Benzene Health Research Consortium Irons Field Expenses 2Q04 Financial Report (J) I m r r sI : () () r C ;a G) oI c..n (J) c..n Page 30 of 62 AUTODATE c..n ..j:::o. LT 7/19/04 BJ 7/22104 Amt. In Irons bank acct: $77,182 Benzene Health Research Consortium Irons Field Expenses 2Q04 Financial Report 3rd Otr 4th Otr 1st Otr 2nd Otr 3rd Otr 4th Otr 1st Otr 2nd Otr 3rd Otr 4th Otr 1st Otr o (J) I m r r sI : () () r C ;a G) ocI.n (J) ccc...nnn Page 31 of 62 AUTODATE IRONS T&E (X81 06) Cost Centers LT 7/19/04 BJ 7/22104 2007 2nd OIL 3rd OIL 4lh OIL Benzene Health Research Consortium Irons Field Expenses 2Q04 Financial Report (J) I m r r sI : () () r C ;a G) oI c..n (J) c..n Page 32 of 62 AUTODATE c..n (J) Cost Centers 1st & 2nd Benzene Health Research Consortium AHS 2Q04 Financial Report LT 7/19/04 BJ 7/14/04 (J) I m r r sI : () () r C ;a G) oI c..n (J) c..n c..n -.....J Adjustment: expense reduced by $52,634; transferred to contingency since these were preconsortia expenses Page 33 of 62 AUTODATE Cost Centers 2nd Ole. 3rd Ole. 4lh Ole. Benzene Health Research Consortium AHS 2Q04 Financial Report LT 7/19/04 BJ 7/14/04 (J) I m r r sI : () () r C ;a G) oI c..n (J) c..n c..n ex> Page 34 of 62 AUTODATE Benzene Health Research Consortium Fudan 2Q04 Financial Report LT 7/19/04 BJ 7/1104 (J) I m r r sI : () () r C ;a G) oI c..n (J) c..n c..n <D Page 35 of 62 AUTODATE Benzene Health Research Consortium Fudan 2Q04 Financial Report LT 7/19/04 BJ 7/1104 (J) I m r r sI : () () r C ;a G) oI c..n (J) c..n (J) o Page 36 of 62 AUTODATE Benzene Health Research Consortium (J) I m r r sI : () () r C ;a G) oI c..n (J) c..n (J) .....lo. Benzene Health Research Consortium SRP + ERP 2Q04 Financial Report (J) I m r r sI : () () r C ;a G) oI c..n (J) c..n (J) Page 38 of 62 AUTODATE I'V Benzene Health Research Consortium . . .:~i#.ri\MM~#li~~:#'ii~~W~WW~:iii@:@iiii:iiiH~\#'@?(::::::::::.: LT 7/19/04 BJ 7/22104 1Q04 budget ajustments to zero our variance to develop more useful budget projections for remainder of program. Change approved by OC at 4/21/04 meeting. (J) I m r r sI : () () r C ;a G) oI c..n (J) c..n(J) Page 39 of 62 c..> AUTODATE Benzene Health Research Consortium SRP + ERP 2Q04 Financial Report :~i#,:jii~i:~:@W~:#'ii~~@~:~~~:W~ LT 7/19/04 BJ 7/22104 (J) I m r r sI : () () r C ;a G) oI c..n (J) c..n (J) ..j:::o. Page 40 of 62 AUTODATE Cost Centers Benzene Health Research Consortium Communications 2Q04 Financial Report (J) I m r r s:I Duplicating/Copies Internal, Postage, Couriers, ( ) Telephone, Meals, Lexis Nexis Searches . . . . .( ) ::~!MMf!lBm::EWM1!lW~W@WWfM~mm@mr~:?:r::r::r::r::r::r:r::::::::::::::::::::::::.:.: r .......Mj~iH;:~~:~f:i.!&i@~}}}}}}}}}}}}}}}}}}}}}}))::::::::::::::: . C "~BLJdgetadjustrr1erltiefiedsbLJdgetiedLJc;ti()rl ;a frorn $1 MM to $550k G) oI LT7/19/04 c..n (J) c..n (J) c..n Page 41 of 62 AUTODATE Cost Centers Benzene Health Research Consortium Communications 2Q04 Financial Report (J) I m r r s:I Duplicating/Copies Internal, Postage, Couriers, ( ) Telephone, Meals, Lexis Nexis Searches () ::~!MMf!lBm::EWM1!lW~W@WWfM~mm@mr~:?: r Mj~iH;:~))i!!ifiii.f:i.!&i@{((((((((((((((((((((((:) C "~BLJdgetadjustrr1erltiefiedsbLJdgetiedLJc;ti()rl ;a frorn $1 MM to $550k G) oI LT7/19/04 c..n (J) c..n (J) (J) Page 42 of 62 AUTODATE * budget adjustment to lower program budget from $500K to $1 OOK, as approved by OC on 11 III 103 LT 7/19/04 RT 7/16/2004 Benzene Health Research Consortium Legal 2Q04 Financial Report (J) I m r r sI : () () r C ;a G) ocI.n (J) c.n Page 43 of 62 AUTODATE (J) -.....J * budget adjustment to lower program budget from $500K to $1 OOK, as approved by OC on 11 III 103 LT 7/19/04 RT 7/16/2004 Benzene Health Research Consortium Legal 2Q04 Financial Report (J) I m r r sI : () () r C ;a G) ocI.n (J) c.n Page 44 of 62 AUTODATE (J) ex> Benzene Health Research Consortium QA-QC 2Q04 Financial Report (J) I m r r sI : () () r C ;a G) oI c..n LT7/19/04 (J) c..n (J) <D Page 45 of 62 AUTODATE Benzene Health Research Consortium QA-QC 2Q04 Financial Report (J) I m r r sI : () () r C ;a G) oI c..n LT7/19/04 (J) c..n o-.....J Page 46 of 62 AUTODATE Cost Centers Benzene Health Research Consortium API Administration 2Q04 Financial Report (J) I m r r s:I LT7/19/04 ( ) RT 7/16/2004 () r Assumptions: C ;a Year 5, 6,7 Less than 1 FTE allocated, G) based allocated cost on 112 FTE oI c..n T&E and Other $15K for Annual Meeting (3rd Quarter) (J) c..n -.....J .....lo. Page 47 of 62 AUTODATE Cost Centers Benzene Health Research Consortium API Administration 2Q04 Financial Report (J) I m r r s:I LT7/19/04 ( ) RT 7/16/2004 () r Assumptions: C ;a Year 5, 6,7 Less than 1 FTE allocated, G) based allocated cost on 112 FTE oI c..n T&E and Other $15K for Annual Meeting (3rd Quarter) (J) c..n -.....J I'V Page 48 of 62 AUTODATE funds for consultant Benzene Health Research Consortium API Administration 2Q04 Financial Report (J) I m r r sI : () () r C ;a G) oI c..n (J) c..n Page 49 of 62 AUTODATE -.....J c..> 2006 2nd Olr. 3rd Olr. Benzene Health Research Consortium API Administration 2Q04 Financial Report 4lh Olr. 1s101r. 2007 2nd Olr. 3rd Olr. 4lh Olr. (J) I m r r sI : () () r C ;a G) oI c..n (J) c..n Page 50 of 62 AUTODATE -.....J ..j:::o. Benzene Health Research Consortium Contingency Fund 2Q04 Financial Report (J) I m r r sI : () LT7/19/04 () r C ;a G) oI c..n (J) c..n c-......n.J 4Q03 Adjustment - per Technical Committee, transfer $48,839 from UCHSC expense detail to contingency because expenses not part of UCHSC grant budget: Page 51 of 62 AUTODATE Benzene Health Research Consortium Contingency Fund 2Q04 Financial Report (J) I m r r sI : () () r C ;a G) oI c..n Page 52 of 62 AUTODATE (J) c..n -.....J (J) Benzene Health Research Consortium Contingency Fund 2Q04 Financial Report (J) I m r r sI : () () r C ;a G) oI c..n Page 53 of 62 AUTODATE (J) c..n -.....J -.....J Benzene Health Research Consortium Contingency Fund 2Q04 Financial Report J-\n0 - t:Xpt:II:::;t;:: lIdll:::;It:1 VI $52,634 from AHS expense detail to contingency because expenses not part of AHS full study budget I . ..JUlIt: c..uu I ..j)LJr\. YId.lll LV UCHSC; seed money exhausted (API & sponsor), expense not included in final grant cost estimate L. ".50UU ltil:) Tees IO U or lJU (this will be a yearly fee, since IRB must review at least once per year) j. LUUL inVOice (~LU,Lj8) trom EMBSI for final feasibility study work (very late billing to API) (J) I m r r sI : () () r C ;a G) ocI.n Page 54 of 62 AUTODATE (J) c.n -.....J ex> LT 7/19/04 RT 7/1 6/2004 Benzene Health Research Consortium Income 2Q04 Financial Reoort (J) I m r r sI : () () r C ;a G) oI c..n Page 55 of 62 AUTODATE (J) c..n -.....J <D Benzene Health Research Consortium Income 2Q04 Financial Reoort 2007 i .......... (J) I m r r sI : () () r C ;a G) oI c..n Page 56 of 62 AUTODATE (J) c..n ex> o Company Name BP (Seed Money) $15,000 $22,500 Inv, # 522922 528453 Date Paid 8-Nov-00 19-Jun-01 Benzene Health Research Consortium Sponsor Invoice Detail 2Q04 Financial Report 2001 2002 3rd - 4th Qtr, 22-Aug-01 $768,941 Inv, # Date Paid 529301 4-0ct-01 9-Jan-02 $806,441 Inv,# Date Paid 532263 22-Feb-02 27-Aug-02 $1,344,069 $112,008 Inv, # 535033 Date Paid 11-0ct-02 2-0ct-02 2003 23-Sep-03 Inv,# Date Paid $1,431,041.00 544951 4-0ec-03 ChevronTexaco $15,000 522923 7-Nov-00 $522,627 529302 9-0ct-01 $537,627 532244 22-Feb-02 $896,046 535034 5-Nov-02 $1,028,700.00 544953 19-Nov-03 ConocoPhillips $15,000 522924 31-0ct-00 $7,500 528574 31-Jul-01 $246,314 529309 17-Sep-01 $268,814 532245 16-Jan-02 $448,023 535035 26-Sep-02 $514,349.00 544954 27-0ct-03 ExxonMobii $0 523540 $1,612,882 $806,441 $806,441 532246 23-Jan-02 11-Feb-02 $1,344,069 535036 13-Sep-02 $1,543,049.00 $771 ,524.50 $771 ,524.50 544956 3-0ct-03 22-Mar-04 Shell Marathon $15,000 523054 24-0ct-00 $15,000 528333 15-May-01 $15,000 528541 14-Aug-01 $507,627 529305 25-Sep-01 $537,627 532247 7-Feb-02 $896,046 $448,023 $448,023 535037 25-Sep-02 10-Feb-03 Marathon Ashland Marathon Oil $1,028,700.00 544958 $514,350 $514,350 $150,000 548582 $50,000 548581 28 Oct 03 14 Jan 04 20-Jan-04 3-Feb-04 Total LT 7/19/04 $120,000 $2,045,509 $5,376,273 $5,936,307 I $8,317,588,00 (J) I m r r sI : () () r C ;a G) oI c..n (J) Page 57 of 62 AUTODATE c..n ex> .....lo. Benzene Health Research Consortium Sponsor Invoice Detail 2Q04 Financial Report TOTAL $4,500,000 $3,000,000 $1,500,000 $4,500,000 $3,000,000 $215,000 $16,715,000 (J) I m r r sI : () () r C ;a G) oI c..n (J) Page 58 of 62 AUTODATE c..n ex> I'V Benzene Health Research Consortium Sponsor Payment Detail 2Q04 Financial Report 3Q03 $- (J) I m r r sI : () () r C ;a G) oI c..n Page 59 of 62 AUTODATE (J) c..n ex> c..> RT 5/5/04 LT 7/19/0 4 Benzene Health Research Consortium Sponsor Payment Detail 2Q04 Financial Report (note - does not include interst income) (J) I m r r sI : () () r C ;a G) oI c..n Page 60 of 62 AUTODATE (J) c..n ex> ..j:::o. Company Date Paid Amount American Petroleum Institute 1/17/2003 $ (I am trying to get this $1.09 1.09 I emoved from the books) BP International Limited 11/8/2000 $ 15,000.00 BP International Ltd 6/19/2001 $ 22,500.00 BP p.Lc. 10/4/2001 $ 768,941.00 BP p.Lc. 2/22/2002 $ 806,441.00 BP p.Lc. BP p.Lc. BP p.Lc. 10/2/2002 $ 112,008.00 10/11/2002 $ 1,344,069.00 12/4/2003 $ 1,431,041.00 $ BP Total 4,500,000.00 Chev ronTexaco Chev ronTexaco Chev ronTexaco Chev ronTexaco Chev ronTexaco 11/7/2000 $ 10/9/2001 $ 2/22/2002 $ 11/5/2002 $ 11/19/2003 $ 15,000.00 522,627.00 537,627.00 896,046.00 1,028,700.00 ChevronTexaco Total $ 3,000,000.00 ConocoPhillips 10/31/2000 $ 15,000.00 ConocoPhillips 7/31/2001 $ 7,500.00 ConocoPhillips 9/17/2001 $ 246,314.00 ConocoPhillips 1/16/2002 $ 268,814.00 ConocoPhillips ConocoPhillips 9/26/2002 $ 448,023.00 ConocoPhillips Total 10/27/2003 $ 514,349.00 $ 1,500,000.00 ExxonMobil Research and Engineering 1/23/2002 $ 806,441.00 ExxonMobil Research and Engineering ExxonMobil 2/11/2002 $ 806,441.00 9/13/2002 $ 1,344,069.00 ExxonMobil ExxonMobil 10/3/2003 $ 771,524.50 3/22/2004 $ 771,524.50 $ ExxonMobil Total 4,500,000.00 Marathon Ashland Petroleum, LLC. 8/14/2001 $ 15,000.00 Marathon Ashland Petroleum, LLC. Marathon Oil Company 1/20/2004 $ 150,000.00 Marathon Ashland Total 2/3/2004 $ 50,000.00 $ 215,000.00 Shell Chem ical (J) I Shell Chem ical m Shell Chem ical r r Shell Chem ical s:I Shell Chem ical () Shell Chem ical () Shell Chem ical r C Shell Chem ical ;a G) oI c..n (J) c..n ecx..>n 10/24/2000 $ 5/15/2001 $ 9/25/2001 $ 2/7/2002 $ 9/25/2002 $ 2/10/2003 $ 10/28/2003 $ 1/13/2004 $ 15,000.00 15,000.00 507,627.00 537,627.00 448,023.00 448,023.00 514,350.00 514,350.00 Shell Chem ical Total $ 3,000,000.00 o0') SH ELL-MCCLU RG-056586 BHRC OVERSIGHT COMMITTEE & COMMITTEE CHAIR CALL ACTION ITEM TABLE Last updated 8/4/04 Budget - Document with UCHSC that API requested interest for 2001,2002 and 2003 unspent funds and was denied, indicating that consortium still feels that it is owed this interest incomesend letter to UCHSC (4/21/04 & 6/21 Outreach - find out relevant professional meeting dates locations and presentation/abstract deadlines via internet (4/21/04 & 6/21/04 Review organizations & contacts with Matt (6/21/04) Budget - Pursue possibility of SHS clinical laboratory income beina used to defrav studv costs Outreach - 2004 Benzene International Symposium o review attendee list for potential follow-up o venue for USEPA, EU and German MAK update o get extra copies of proceedings (Chem. BioI. Interaction special issue and individual SHS reprints) J. Wagner & B. Jarnot M. Todd/L. Russo Outreach Contacts J. Wagner Technical Committee Outreach - outreach coordination, make sure circulate summaries as contacts are made 2004 Annual Meeting - Develop a robust closing session for the 2004 mootinn M.Todd P. Clegg Drafted Due 6/30/04 ongoing In progress Updates will be posted to readsheet on website (J) I m r r sI : () () r C ;a G) oI c..n (J) AUTOPATH c..n ex> -.....J BHRC OVERSIGHT COMMITTEE & COMMITTEE CHAIR CALL ACTION ITEM TABLE Last updated 8/4/04 (J) I m r r sI : () () r C ;a G) oI c..n AUTOPATH (J) c..n ex> ex> BHRC OVERSIGHT COMMITTEE & COMMITTEE CHAIR CALL ACTION ITEM TABLE Last updated 8/4/04 (J) I m r r sI : () () r C ;a G) oI c..n (J) AUTOPATH c..n ex> <D BHRC OVERSIGHT COMMITTEE & COMMITTEE CHAIR CALL ACTION ITEM TABLE Last updated 8/4/04 (J) I m r r sI : () () r C ;a G) oI c..n AUTOPATH (J) c..n <D o Draft 6/2/04 BHRC Regulatory & Technical Outreach Plan Action Outcome/Comments Patrick & I Set up meeting with EPA Stuart contacts (probably in DC) 3004 I Pending Technical Contact Jerry Rice for advice on Committee how to contact 4004 I Pending Email to organizers of International Benzene EU Environment DG Patrick Symposium (Dr. Greim) I recommending that they consider I 3004 I Pending whether EU or other Europe - lators should be invited. Contact by phone or in pers Anticipate attendance at German MAK International Benzene I Symposium, where investigators 4004 I Completed will be presenting SHS information Health Canada (Betty Meeks) Contact Geoff Granville (Shell P t B . I Canada) and Roger Keefe a sy & nan (Imperial Oil) for advice for 3004 Pending contact OSHA Technical Committee Identify OSHA contact and offer briefing 1/2005 Pending I Need to identify BHRC lead (J) ACGIH (Jim Pierce) Stuart (on TLV committee) ACGIH is not currently working on benzene; seek opportunity to inform as an FYI 2005 Pending I m Ir r Australia (info@nohsc.gov.au or _r_ "'="- _"_ BHRCOC members Pursue company contacts in Australia 2004 Pending sI : () () r C ;a G) I 0 c..n Page 1 of 2 (J) c..n <D .....lo.